148 related articles for article (PubMed ID: 21063397)
1. LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.
Matsuda R; Enokida H; Chiyomaru T; Kikkawa N; Sugimoto T; Kawakami K; Tatarano S; Yoshino H; Toki K; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Br J Cancer; 2011 Jan; 104(2):376-86. PubMed ID: 21063397
[TBL] [Abstract][Full Text] [Related]
2. CpG hypermethylation of collagen type I alpha 2 contributes to proliferation and migration activity of human bladder cancer.
Mori K; Enokida H; Kagara I; Kawakami K; Chiyomaru T; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Int J Oncol; 2009 Jun; 34(6):1593-602. PubMed ID: 19424577
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-500a-3p inhibits cell proliferation and invasion by targeting lymphocyte antigen 6 complex locus K (LY6K) in human non-small cell lung cancer.
Liao XH; Xie Z; Guan CN
Neoplasma; 2018 Sep; 65(5):673-682. PubMed ID: 30249107
[TBL] [Abstract][Full Text] [Related]
4. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.
Uchida Y; Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2013 Jan; 31(1):115-23. PubMed ID: 21396852
[TBL] [Abstract][Full Text] [Related]
5. The regulatory mechanism of the LY6K gene expression in human breast cancer cells.
Kong HK; Yoon S; Park JH
J Biol Chem; 2012 Nov; 287(46):38889-900. PubMed ID: 22988241
[TBL] [Abstract][Full Text] [Related]
6. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.
Chiyomaru T; Enokida H; Tatarano S; Kawahara K; Uchida Y; Nishiyama K; Fujimura L; Kikkawa N; Seki N; Nakagawa M
Br J Cancer; 2010 Mar; 102(5):883-91. PubMed ID: 20160723
[TBL] [Abstract][Full Text] [Related]
7. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
8. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
[TBL] [Abstract][Full Text] [Related]
9. Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.
AlHossiny M; Luo L; Frazier WR; Steiner N; Gusev Y; Kallakury B; Glasgow E; Creswell K; Madhavan S; Kumar R; Upadhyay G
Cancer Res; 2016 Jun; 76(11):3376-86. PubMed ID: 27197181
[TBL] [Abstract][Full Text] [Related]
10. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
Ishikawa N; Takano A; Yasui W; Inai K; Nishimura H; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Cancer Res; 2007 Dec; 67(24):11601-11. PubMed ID: 18089789
[TBL] [Abstract][Full Text] [Related]
11. miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer.
Kim YS; Park SJ; Lee YS; Kong HK; Park JH
Oncotarget; 2016 Jul; 7(27):42261-42273. PubMed ID: 27304060
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma.
Kong HK; Park SJ; Kim YS; Kim KM; Lee HW; Kang HG; Woo YM; Park EY; Ko JY; Suzuki H; Chun KH; Song E; Jang KY; Park JH
Oncotarget; 2016 Aug; 7(34):55677-55689. PubMed ID: 27494879
[TBL] [Abstract][Full Text] [Related]
13. Serological antibodies against LY6K as a diagnostic biomarker in esophageal squamous cell carcinoma.
Zhang B; Zhang Z; Zhang X; Gao X; Kernstine KH; Zhong L
Biomarkers; 2012 Jun; 17(4):372-8. PubMed ID: 22515502
[TBL] [Abstract][Full Text] [Related]
14. TEX101, a glycoprotein essential for sperm fertility, is required for stable expression of Ly6k on testicular germ cells.
Endo S; Yoshitake H; Tsukamoto H; Matsuura H; Kato K; Sakuraba M; Takamori K; Fujiwara H; Takeda S; Araki Y
Sci Rep; 2016 Mar; 6():23616. PubMed ID: 27005865
[TBL] [Abstract][Full Text] [Related]
15. CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancer.
Matsumoto M; Kawakami K; Enokida H; Toki K; Matsuda R; Chiyomaru T; Nishiyama K; Kawahara K; Seki N; Nakagawa M
Int J Mol Med; 2010 Aug; 26(2):241-7. PubMed ID: 20596604
[TBL] [Abstract][Full Text] [Related]
16. Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.
Suda T; Tsunoda T; Daigo Y; Nakamura Y; Tahara H
Cancer Sci; 2007 Nov; 98(11):1803-8. PubMed ID: 17784873
[TBL] [Abstract][Full Text] [Related]
17. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
18. LY6K-AS lncRNA is a lung adenocarcinoma prognostic biomarker and regulator of mitotic progression.
Ali MM; Di Marco M; Mahale S; Jachimowicz D; Kosalai ST; Reischl S; Statello L; Mishra K; Darnfors C; Kanduri M; Kanduri C
Oncogene; 2021 Apr; 40(13):2463-2478. PubMed ID: 33674747
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancers.
Ambatipudi S; Gerstung M; Pandey M; Samant T; Patil A; Kane S; Desai RS; Schäffer AA; Beerenwinkel N; Mahimkar MB
Genes Chromosomes Cancer; 2012 Feb; 51(2):161-73. PubMed ID: 22072328
[TBL] [Abstract][Full Text] [Related]
20. GPI-anchored protein complex, LY6K/TEX101, is required for sperm migration into the oviduct and male fertility in mice.
Fujihara Y; Okabe M; Ikawa M
Biol Reprod; 2014 Mar; 90(3):60. PubMed ID: 24501175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
